These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 18703623)

  • 1. The pairing of a selective estrogen receptor modulator, bazedoxifene, with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention.
    Kharode Y; Bodine PV; Miller CP; Lyttle CR; Komm BS
    Endocrinology; 2008 Dec; 149(12):6084-91. PubMed ID: 18703623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S; Komm BS
    Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland.
    Peano BJ; Crabtree JS; Komm BS; Winneker RC; Harris HA
    Endocrinology; 2009 Apr; 150(4):1897-903. PubMed ID: 19022889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bazedoxifene when paired with conjugated estrogens is a new paradigm for treatment of postmenopausal women.
    Pinkerton JV; Stovall DW
    Expert Opin Investig Drugs; 2010 Dec; 19(12):1613-21. PubMed ID: 21073353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
    Komm BS; Mirkin S; Jenkins SN
    Steroids; 2014 Nov; 90():71-81. PubMed ID: 24929044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
    Pickar JH; Komm BS
    Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
    Pinkerton JV; Pickar JH; Racketa J; Mirkin S
    Climacteric; 2012 Oct; 15(5):411-8. PubMed ID: 22853444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats.
    Komm BS; Vlasseros F; Samadfam R; Chouinard L; Smith SY
    Bone; 2011 Sep; 49(3):376-86. PubMed ID: 21658483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause.
    Tella SH; Gallagher JC
    Expert Opin Pharmacother; 2013 Dec; 14(17):2407-20. PubMed ID: 24093499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.
    Sharifi M; Lewiecki EM
    Expert Rev Clin Pharmacol; 2014 May; 7(3):281-91. PubMed ID: 24580081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
    Pickar JH; Mirkin S
    Menopause Int; 2010 Sep; 16(3):121-8. PubMed ID: 20956688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bazedoxifene/conjugated estrogens combination for the treatment of the vasomotor symptoms associated with menopause and for prevention of osteoporosis in postmenopausal women.
    Palacios S; Mejía Ríos A
    Drugs Today (Barc); 2015 Feb; 51(2):107-16. PubMed ID: 25756066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-selective estrogen complex bazedoxifene and conjugated estrogens for the treatment of menopausal vasomotor symptoms.
    Stovall DW; Tanner-Kurtz K; Pinkerton JV
    Drugs; 2011 Sep; 71(13):1649-57. PubMed ID: 21902289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprela, a single tablet formulation of bazedoxifene and conjugated equine estrogens (Premarin) for the potential treatment of menopausal symptoms.
    Stovall DW
    Curr Opin Investig Drugs; 2010 Apr; 11(4):464-71. PubMed ID: 20336595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes.
    Smith CL; Santen RJ; Komm B; Mirkin S
    Breast Cancer Res; 2014 Jun; 16(3):212. PubMed ID: 25928299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model.
    Pinkerton JV; Komm BS; Mirkin S
    Climacteric; 2013 Dec; 16(6):618-28. PubMed ID: 23805785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis.
    Lewiecki EM
    Expert Opin Investig Drugs; 2007 Oct; 16(10):1663-72. PubMed ID: 17922629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: insights into the unique antagonistic effects of bazedoxifene on conjugated estrogens.
    Chang KC; Wang Y; Bodine PV; Nagpal S; Komm BS
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):117-24. PubMed ID: 19914376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
    Palacios S; Currie H; Mikkola TS; Dragon E
    Maturitas; 2015 Apr; 80(4):435-40. PubMed ID: 25684082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential biochemical and cellular actions of Premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination.
    Berrodin TJ; Chang KC; Komm BS; Freedman LP; Nagpal S
    Mol Endocrinol; 2009 Jan; 23(1):74-85. PubMed ID: 19036900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.